Your browser doesn't support javascript.
loading
Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
Nowak, Natalia; Skupien, Jan; Smiles, Adam M; Yamanouchi, Masayuki; Niewczas, Monika A; Galecki, Andrzej T; Duffin, Kevin L; Breyer, Matthew D; Pullen, Nick; Bonventre, Joseph V; Krolewski, Andrzej S.
Afiliação
  • Nowak N; Section on Genetics and Epidemiology, Research Divisions, Joslin Diabetes Center, Boston, Massachusetts, USA; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA; Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland.
  • Skupien J; Section on Genetics and Epidemiology, Research Divisions, Joslin Diabetes Center, Boston, Massachusetts, USA; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA; Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland. Electronic address: Jan
  • Smiles AM; Section on Genetics and Epidemiology, Research Divisions, Joslin Diabetes Center, Boston, Massachusetts, USA.
  • Yamanouchi M; Section on Genetics and Epidemiology, Research Divisions, Joslin Diabetes Center, Boston, Massachusetts, USA; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Niewczas MA; Section on Genetics and Epidemiology, Research Divisions, Joslin Diabetes Center, Boston, Massachusetts, USA; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Galecki AT; Institute of Gerontology, University of Michigan Medical School, Ann Arbor, Michigan, USA; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
  • Duffin KL; Lilly Research Laboratories, Eli Lilly & Company Inc. Corporate Center Indianapolis, Indiana, USA.
  • Breyer MD; Lilly Research Laboratories, Eli Lilly & Company Inc. Corporate Center Indianapolis, Indiana, USA.
  • Pullen N; Pfizer Inc., 610 Main Street, Cambridge, Massachusetts, USA.
  • Bonventre JV; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA; Renal Division, Brigham & Women Hospital, Boston, Massachusetts, USA.
  • Krolewski AS; Section on Genetics and Epidemiology, Research Divisions, Joslin Diabetes Center, Boston, Massachusetts, USA; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: Andrzej.krolewski@joslin.harvard.edu.
Kidney Int ; 93(5): 1198-1206, 2018 05.
Article em En | MEDLINE | ID: mdl-29398132
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article